Screening Outside the Catalytic Site: Inhibition of Macromolecular Interactions Through Structure-Based Virtual Ligand Screening Experiments
2008

Inhibition of Protein-Membrane Interactions Through Virtual Screening

Sample size: 1018 publication Evidence: moderate

Author Information

Author(s): Sperandio Olivier, Miteva Maria A, Segers Kenneth, Nicolaes Gerry A. F, Villoutreix Bruno O

Primary Institution: Inserm U648, University of Paris 5

Hypothesis

Can small molecules effectively inhibit protein-membrane interactions?

Conclusion

The study demonstrates that small molecules can disrupt protein-membrane interactions, offering new avenues for drug development.

Supporting Evidence

  • Recent studies show that small molecules can target protein-protein interactions effectively.
  • Virtual screening methods have been successful in identifying potential drug-like compounds.
  • Protein-membrane interactions are crucial for many biological processes and can be targeted for drug development.

Takeaway

Scientists found that tiny molecules can stop proteins from sticking to cell membranes, which could help create new medicines.

Methodology

The study used in silico screening followed by functional assays and surface plasmon resonance to identify inhibitors of protein-membrane interactions.

Limitations

The study acknowledges that drug discovery is costly and time-consuming, and that in silico methods have limitations.

Digital Object Identifier (DOI)

10.2174/1874091X0080201002918

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication